Megestrol acetate increases the proliferation, migration, and adipogenic differentiation of adipose-derived stem cells via glucocorticoid receptor

Jong Hyuk Sung, Hyo Sun An, Jin Hyun Jeong, Soyoung Shin, Seung Yong Song

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Because adipose-derived stem cells (ASCs) are usually expanded to acquire large numbers of cells for therapeutic applications, it is important to increase the production yield and regenerative potential during expansion. Therefore, a tremendous need exists for alternative ASC stimuli during cultivation to increase the proliferation and adipogenic differentiation of ASCs. The present study primarily investigated the involvement of megestrol acetate (MA), a progesterone analog, in the stimulation of ASCs, and identifies the target receptors underlying stimulation. Mitogenic and adipogenic effects of MA were investigated in vitro, and pharmacological inhibition and small interfering (si) RNA techniques were used to identify the molecular mechanisms involved in the MA-induced stimulation of ASCs. MA significantly increased the proliferation, migration, and adipogenic differentiation of ASCs in a dose-dependent manner. Glucocorticoid receptor (GR) is highly expressed compared with other nuclear receptors in ASCs, and this receptor is phosphorylated after MA treatment. MA also upregulated genes downstream of GR in ASCs, including ANGPTL4, DUSP1, ERRF11, FKBP5, GLUL, and TSC22D3. RU486, a pharmacological inhibitor of GR, and transfection of siGR significantly attenuated MA-induced proliferation, migration, and adipogenic differentiation of ASCs. Although the adipogenic differentiation potential of MA was inferior to that of dexamethasone, MA had mitogenic effects in ASCs. Collectively, these results indicate thatMAincreases the proliferation, migration, and adipogenic differentiation of ASCs via GR phosphorylation.

Original languageEnglish
Pages (from-to)789-799
Number of pages11
JournalStem Cells Translational Medicine
Volume4
Issue number7
DOIs
Publication statusPublished - 2015 Jul 1

Fingerprint

Megestrol Acetate
Glucocorticoid Receptors
Stem Cells
Pharmacology
Cytoplasmic and Nuclear Receptors
Small Interfering RNA
Transfection
Progesterone

All Science Journal Classification (ASJC) codes

  • Developmental Biology
  • Cell Biology

Cite this

@article{5db9775394fe4f688573a2ae85d16b70,
title = "Megestrol acetate increases the proliferation, migration, and adipogenic differentiation of adipose-derived stem cells via glucocorticoid receptor",
abstract = "Because adipose-derived stem cells (ASCs) are usually expanded to acquire large numbers of cells for therapeutic applications, it is important to increase the production yield and regenerative potential during expansion. Therefore, a tremendous need exists for alternative ASC stimuli during cultivation to increase the proliferation and adipogenic differentiation of ASCs. The present study primarily investigated the involvement of megestrol acetate (MA), a progesterone analog, in the stimulation of ASCs, and identifies the target receptors underlying stimulation. Mitogenic and adipogenic effects of MA were investigated in vitro, and pharmacological inhibition and small interfering (si) RNA techniques were used to identify the molecular mechanisms involved in the MA-induced stimulation of ASCs. MA significantly increased the proliferation, migration, and adipogenic differentiation of ASCs in a dose-dependent manner. Glucocorticoid receptor (GR) is highly expressed compared with other nuclear receptors in ASCs, and this receptor is phosphorylated after MA treatment. MA also upregulated genes downstream of GR in ASCs, including ANGPTL4, DUSP1, ERRF11, FKBP5, GLUL, and TSC22D3. RU486, a pharmacological inhibitor of GR, and transfection of siGR significantly attenuated MA-induced proliferation, migration, and adipogenic differentiation of ASCs. Although the adipogenic differentiation potential of MA was inferior to that of dexamethasone, MA had mitogenic effects in ASCs. Collectively, these results indicate thatMAincreases the proliferation, migration, and adipogenic differentiation of ASCs via GR phosphorylation.",
author = "Sung, {Jong Hyuk} and An, {Hyo Sun} and Jeong, {Jin Hyun} and Soyoung Shin and Song, {Seung Yong}",
year = "2015",
month = "7",
day = "1",
doi = "10.5966/sctm.2015-0009",
language = "English",
volume = "4",
pages = "789--799",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "7",

}

Megestrol acetate increases the proliferation, migration, and adipogenic differentiation of adipose-derived stem cells via glucocorticoid receptor. / Sung, Jong Hyuk; An, Hyo Sun; Jeong, Jin Hyun; Shin, Soyoung; Song, Seung Yong.

In: Stem Cells Translational Medicine, Vol. 4, No. 7, 01.07.2015, p. 789-799.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Megestrol acetate increases the proliferation, migration, and adipogenic differentiation of adipose-derived stem cells via glucocorticoid receptor

AU - Sung, Jong Hyuk

AU - An, Hyo Sun

AU - Jeong, Jin Hyun

AU - Shin, Soyoung

AU - Song, Seung Yong

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Because adipose-derived stem cells (ASCs) are usually expanded to acquire large numbers of cells for therapeutic applications, it is important to increase the production yield and regenerative potential during expansion. Therefore, a tremendous need exists for alternative ASC stimuli during cultivation to increase the proliferation and adipogenic differentiation of ASCs. The present study primarily investigated the involvement of megestrol acetate (MA), a progesterone analog, in the stimulation of ASCs, and identifies the target receptors underlying stimulation. Mitogenic and adipogenic effects of MA were investigated in vitro, and pharmacological inhibition and small interfering (si) RNA techniques were used to identify the molecular mechanisms involved in the MA-induced stimulation of ASCs. MA significantly increased the proliferation, migration, and adipogenic differentiation of ASCs in a dose-dependent manner. Glucocorticoid receptor (GR) is highly expressed compared with other nuclear receptors in ASCs, and this receptor is phosphorylated after MA treatment. MA also upregulated genes downstream of GR in ASCs, including ANGPTL4, DUSP1, ERRF11, FKBP5, GLUL, and TSC22D3. RU486, a pharmacological inhibitor of GR, and transfection of siGR significantly attenuated MA-induced proliferation, migration, and adipogenic differentiation of ASCs. Although the adipogenic differentiation potential of MA was inferior to that of dexamethasone, MA had mitogenic effects in ASCs. Collectively, these results indicate thatMAincreases the proliferation, migration, and adipogenic differentiation of ASCs via GR phosphorylation.

AB - Because adipose-derived stem cells (ASCs) are usually expanded to acquire large numbers of cells for therapeutic applications, it is important to increase the production yield and regenerative potential during expansion. Therefore, a tremendous need exists for alternative ASC stimuli during cultivation to increase the proliferation and adipogenic differentiation of ASCs. The present study primarily investigated the involvement of megestrol acetate (MA), a progesterone analog, in the stimulation of ASCs, and identifies the target receptors underlying stimulation. Mitogenic and adipogenic effects of MA were investigated in vitro, and pharmacological inhibition and small interfering (si) RNA techniques were used to identify the molecular mechanisms involved in the MA-induced stimulation of ASCs. MA significantly increased the proliferation, migration, and adipogenic differentiation of ASCs in a dose-dependent manner. Glucocorticoid receptor (GR) is highly expressed compared with other nuclear receptors in ASCs, and this receptor is phosphorylated after MA treatment. MA also upregulated genes downstream of GR in ASCs, including ANGPTL4, DUSP1, ERRF11, FKBP5, GLUL, and TSC22D3. RU486, a pharmacological inhibitor of GR, and transfection of siGR significantly attenuated MA-induced proliferation, migration, and adipogenic differentiation of ASCs. Although the adipogenic differentiation potential of MA was inferior to that of dexamethasone, MA had mitogenic effects in ASCs. Collectively, these results indicate thatMAincreases the proliferation, migration, and adipogenic differentiation of ASCs via GR phosphorylation.

UR - http://www.scopus.com/inward/record.url?scp=84937020224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937020224&partnerID=8YFLogxK

U2 - 10.5966/sctm.2015-0009

DO - 10.5966/sctm.2015-0009

M3 - Article

AN - SCOPUS:84937020224

VL - 4

SP - 789

EP - 799

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 7

ER -